TenNor Therapeutics Suzhou Ltd. Class H Statistics
Want to see HK:6872 full AI Analyst Report?
TenNor Therapeutics Suzhou Ltd. Class H (6872) Stock Statistics & Valuation Metrics
Total Valuation
TenNor Therapeutics Suzhou Ltd. Class H has a market cap or net worth of HKD 3.90B. The enterprise value is HKD 10.69B.
- Market Cap
- HKD 3.90B
- Enterprise Value
- HKD 10.69B
Share Statistics
TenNor Therapeutics Suzhou Ltd. Class H has 52,328,926 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 52,328,926
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
TenNor Therapeutics Suzhou Ltd. Class H’s return on equity (ROE) is -1.00 and return on invested capital (ROIC) is -57.19%.
- Return on Equity (ROE)
- -1.00
- Return on Assets (ROA)
- -0.67
- Return on Invested Capital (ROIC)
- -57.19%
- Return on Capital Employed (ROCE)
- -0.63
- Revenue Per Employee
- 0
- Profits Per Employee
- -2.74M
- Employee Count
- 56
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of TenNor Therapeutics Suzhou Ltd. Class H is -21.08. TenNor Therapeutics Suzhou Ltd. Class H’s PEG ratio is -0.21.
- PE Ratio
- -21.08
- PS Ratio
- 0.00
- PB Ratio
- 20.99
- Price to FCF
- -37.26
- Price to Operating Cash Flow
- -37.04
- PEG Ratio
- -0.21
Income Statement
In the last 12 months, TenNor Therapeutics Suzhou Ltd. Class H had revenue of 0 and earned -153.24M in profits. Earnings per share was -2.96.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- -118.67M
- Pretax Income
- -153.24M
- Net Income
- -153.24M
- EBITDA
- -150.18M
- Earnings Per Share (EPS)
- -2.96
Cash Flow
In the last 12 months, operating cash flow was -33.14M and capital expenditures -74,853, giving a free cash flow of -33.21M billion.
- Operating Cash Flow
- -33.14M
- Free Cash Flow
- -33.21M
- Free Cash Flow per Share
- -1.69
Dividends & Yields
TenNor Therapeutics Suzhou Ltd. Class H pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -2.68%
- Earnings Yield
- -4.74%
Stock Price Statistics
- Beta
- -0.55
- 52-Week Price Change
- -65.26%
- 50-Day Moving Average
- 99.02
- 200-Day Moving Average
- 162.75
- Relative Strength Index (RSI)
- 37.87
- Average Volume (3m)
- 102.40K
Important Dates
TenNor Therapeutics Suzhou Ltd. Class H upcoming earnings date is ―, Before Open (Confirmed).
- Last Earnings Date
- Aug 26, 2026
- Next Earnings Date
- ―
- Ex-Dividend Date
- ―
Financial Position
TenNor Therapeutics Suzhou Ltd. Class H as a current ratio of 5.02, with Debt / Equity ratio of 18.62%
- Current Ratio
- 5.02
- Quick Ratio
- 5.02
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 1.03
- Interest Coverage Ratio
- -80.07
Taxes
In the past 12 months, TenNor Therapeutics Suzhou Ltd. Class H has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
TenNor Therapeutics Suzhou Ltd. Class H EV to EBITDA ratio is -20.71, with an EV/FCF ratio of -35.49.
- EV to Sales
- 0.00
- EV to EBITDA
- -20.71
- EV to Free Cash Flow
- -35.49
- EV to Operating Cash Flow
- -35.67
Balance Sheet
TenNor Therapeutics Suzhou Ltd. Class H has HKD 183.76M in cash and marketable securities with HKD 28.65M in debt, giving a net cash position of HKD 155.11M billion.
- Cash & Marketable Securities
- HKD 183.76M
- Total Debt
- HKD 28.65M
- Net Cash
- HKD 155.11M
- Net Cash Per Share
- HKD 2.96
- Tangible Book Value Per Share
- HKD 0.00
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Scores
- Smart Score
- 8
- AI Score
- 41

